PRF Technologies (PRFX) Retained Earnings (2019 - 2025)

PRF Technologies (PRFX) posted quarterly Retained Earnings of $69.8 million for Q4 2025, up 19.83% year-on-year from $58.3 million in Q4 2024, and up 218.83% on a QoQ basis from -$58.8 million in Q2 2025.

PRF Technologies (PRFX) Retained Earnings (2019 - 2025) Analysis & Trends

PRF Technologies (PRFX) has reported Retained Earnings for 7 consecutive years, with $69.8 million the latest figure, recorded in Q4 2025.

  • Quarterly Retained Earnings rose 19.83% year-over-year to $69.8 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $69.8 million (up 19.83% YoY) and the FY2025 annual result came in at $69.8 million, up 19.83% from the prior year.
  • Retained Earnings advanced to $69.8 million in Q4 2025 per PRFX's latest filing, from -$58.8 million in the prior quarter.
  • Over the last five years, Retained Earnings for PRFX reached as high as $69.8 million in Q4 2025 and fell as low as -$58.8 million in Q2 2025.
  • A 5-year average of -$11.8 million and a median of -$25.4 million in 2022 frame the typical range for Retained Earnings.
  • Annual changes were most pronounced in 2023 — Retained Earnings plunged 103.32% — and 2024, when it surged 4135.66%.
  • Year by year, Retained Earnings stood at $41.7 million in 2021, then rose by 4.15% to $43.4 million in 2022, then tumbled by 103.32% to -$1.4 million in 2023, then jumped by 4135.66% to $58.3 million in 2024, then grew by 19.83% to $69.8 million in 2025.
  • According to Business Quant data, Retained Earnings over the past three periods registered $69.8 million, -$58.8 million, and $58.3 million for Q4 2025, Q2 2025, and Q4 2024 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Retained Earnings (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - 37.04 Bn
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 28.20 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 1.11 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 4.54 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 8.83 Bn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -1.81 Bn
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 18.66 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 589.60 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn -2.13 Bn
10 PRF Technologies 745,168.93 451,168.93 - 69.83 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 69.83 Mn
Jun 30, 2025 -58.77 Mn
Dec 31, 2024 58.28 Mn
Jun 30, 2024 -54.68 Mn
Mar 31, 2024 -47.37 Mn
Dec 31, 2023 -1.44 Mn
Sep 30, 2023 -36.97 Mn
Jun 30, 2023 -37.01 Mn
Mar 31, 2023 -34.83 Mn
Dec 31, 2022 43.45 Mn
Sep 30, 2022 -29.35 Mn
Jun 30, 2022 -27.24 Mn
Mar 31, 2022 -25.42 Mn
Dec 31, 2021 41.72 Mn
Sep 30, 2021 -21.99 Mn
Jun 30, 2021 -20.22 Mn
Mar 31, 2021 -18.52 Mn
Dec 31, 2020 33.02 Mn
Jun 30, 2020 -14.39 Mn
Dec 31, 2019 -12.43 Mn